M:M Bio Limited
- Biotech or pharma, therapeutic R&D
Molecule to Medicine (MTM; previously M:M Bio) is a global ecosystem of connected biotech companies with shared operations, based in the UK, Europe, and Australia. Focused on developing therapeutics for high unmet needs in oncology, immuno-oncology, inflammation, neurodegeneration, autoimmune disease, and metabolic dysfunction, MTM provides investment and partnering opportunities across its portfolio. Led by experienced biotech entrepreneurs, we specialize in co-creating and scaling innovative companies within our global ecosystem. Our model blends experienced drug discovery and clinical development with agile operations, enabling rapid, robust company launches and growth. With deep expertise in drug discovery and operational agility, we anticipate trends, foster breakthroughs, and accelerate the delivery of transformative medicines. MTM is actively seeking capital to further grow and expand our unique, globally connected model, driving the next generation of biotech innovation.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}